2025-07-26 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc (UNH) based on the provided data. The report is in English, contains simple numerical summaries, and includes analysis of each section, culminating in a comprehensive overview.

**Report on UnitedHealth Group Inc (UNH)**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** UNH
*   **Company Description:** UnitedHealth Group Inc is a diversified health care company providing a wide range of health benefits and services.
*   **UNH Cumulative Return:** 11.48%
*   **VOO (S&P 500) Cumulative Return:** 99.66%
*   **Relative Divergence:**
    *   Max: 55.3
    *   Min: -85.2
    *   Current: -84.0
    *   Relative Divergence (Position): 0.9

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO) during the period examined. The relative divergence of -84.0 indicates a substantial gap in cumulative returns. The Relative Divergence (Position) of 0.9 suggests that UNH's underperformance is near the most negative point in its historical range relative to the S&P 500.

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD     | Alpha  | Beta | Cap(B) |
|------------|---------|---------|--------|------|--------|
| 2015-2017  | 65.0%   | 56.6%   | 36.0%  | 0.0  | 200.0  |
| 2016-2018  | 52.0%   | 63.7%   | 34.0%  | 0.0  | 226.0  |
| 2017-2019  | 38.0%   | 63.7%   | 9.0%   | 0.3  | 266.7  |
| 2018-2020  | -21.0%  | 63.7%   | -40.0% | 0.4  | 318.1  |
| 2019-2021  | 36.0%   | 61.0%   | -13.0% | 0.4  | 455.5  |
| 2020-2022  | 28.0%   | 66.9%   | 26.0%  | 0.4  | 480.9  |
| 2021-2023  | 33.0%   | 67.5%   | 15.0%  | 0.4  | 477.6  |
| 2022-2024  | -31.0%  | 68.6%   | -57.0% | 0.3  | 458.9  |
| 2023-2025  | -65.0%  | 75.7%   | -116.0%| 0.2  | 255.0  |

**Analysis:**

*   **CAGR & MDD:** The table shows fluctuating performance over different periods.  Recent periods (2022-2025) show significant negative CAGR and high Maximum Drawdown (MDD), indicating substantial losses and volatility.
*   **Alpha:**  Alpha values are also highly variable, with recent periods showing significantly negative alpha, suggesting UNH is underperforming relative to its risk-adjusted benchmark.
*   **Beta:** Beta values are consistently low (near 0), indicating UNH's price is less volatile than the market.

**2. Recent Price Action**

*   **Current Price:** 281.06
*   **Previous Close:** 278.58
*   **Change:** 0.89 (Positive)
*   **5-Day Moving Average:** 283.88
*   **20-Day Moving Average:** 297.98
*   **60-Day Moving Average:** 315.17

**Analysis:**  The current price is slightly up from the previous close. However, the stock price is below all three moving averages (5-day, 20-day, and 60-day), suggesting a downward trend in the short to medium term.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 33.11 (Approaching Oversold)
*   **PPO:** -0.28 (Negative)
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Divergence Change:** 0.9 (+, Short-term Increase)
*   **Expected Return:** 1114.9% (Long-Term, vs. S&P 500)

**Analysis:**

*   **MRI:** Indicates low market risk, generally favorable.
*   **RSI:** The RSI is below 40, edging closer to oversold levels, which *could* indicate a potential buying opportunity *if* other factors align.
*   **PPO:**  The negative PPO confirms the downward trend indicated by the moving averages.
*   **Hybrid Signal:** The signal is recommending buying a small position while exercising caution.
*   **Delta_Previous_Relative_Divergence:** The increase in relative divergence suggests short-term upward momentum.
*   **Expected Return:**  The extraordinarily high expected return should be viewed with extreme caution.  It suggests a model predicting significant outperformance over the S&P 500 over the long term (2+ years), but this contradicts the recent underperformance.  Further investigation is required to understand the basis for this optimistic prediction.
*   **Price change:** Given the price is up (change=0.89), there is no indication of significant volatility or rapid movement in today's price action.

**4. Recent News & Significant Events**

*   **[2025-07-24]:** Major business developments, regulatory changes, or market events impacting UNH.
*   **[2025-07-23]:** Analysts discussing UNH's performance and outlook amid industry trends and global economic factors.
*   **[2025-07-25]:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **[2025-07-26]:** Market experts highlighting risks and opportunities for UNH.

**Analysis:** The news snippets point to a dynamic environment for UNH, with recent events causing volatility and scrutiny from analysts. These factors need to be considered when evaluating the company's future prospects.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출           |
|------------|-------|----------------|
| 2025-05-07 | 6.9   | 109.58 B$     |
| 2024-11-04 | 6.56  | 100.82 B$     |
| 2024-08-09 | 4.58  | 98.86 B$      |
| 2024-05-09 | -1.53 | 99.80 B$      |
| 2025-05-07 | -1.53 | 99.80 B$      |

**Analysis:**
Earnings Per Share (EPS) seems volatile. The first and last entries are duplicates, showing significant inconsistencies in the data. The most recent earning analysis from 2025-05-07 shows an EPS of 6.9 and revenue of 109.58 B$.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue      | Profit Margin |
|--------------|--------------|---------------|
| 2025-03-31   | $109.58B    | 21.70%        |
| 2024-12-31   | $100.81B    | 21.14%        |
| 2024-09-30   | $100.82B    | 22.84%        |
| 2024-06-30   | $98.86B     | 22.31%        |
| 2024-03-31   | $99.80B     | 23.05%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-03-31   | $95.04B   | 6.62%  |
| 2024-12-31   | $92.66B   | 5.98%  |
| 2024-09-30   | $94.53B   | 6.41%  |
| 2024-06-30   | $89.36B   | 4.72%  |
| 2024-03-31   | $86.69B   | -1.63% |

**Analysis:**

*   **Revenue:**  Revenue has generally increased over the last five quarters.
*   **Profit Margin:** Profit margins have remained relatively stable, fluctuating between 21% and 23%.
*   **Equity:**  Equity has also shown a general upward trend.
*   **ROE:** Return on Equity (ROE) has been positive in recent quarters, indicating profitability. However, there was a significant negative ROE in the quarter ending March 31, 2024.

**7. Comprehensive Analysis**

Based on the provided data, UnitedHealth Group (UNH) presents a mixed picture:

*   **Underperformance:** UNH has significantly underperformed the S&P 500 recently, but long-term forecasts (expected return) are very optimistic (though potentially unreliable).
*   **Technical Indicators:** Technical indicators suggest a current downward trend, with the price below key moving averages and the RSI approaching oversold territory.
*   **Recent News:** Recent news indicates volatility and scrutiny surrounding the company, potentially related to market events, regulatory changes, or business developments.
*   **Earnings & Financials:** Revenue and equity have generally been increasing, and profit margins and ROE have been positive. However, inconsistencies in earnings per share (EPS) require caution.
*   **MRI:** A low MRI indicates low market risk.

**Conclusion:** UNH appears to be facing some headwinds, reflected in its underperformance, downward price trend, and recent news events. While the financials (revenue, equity, profit margins) are generally positive, potential investors should exercise caution and conduct further due diligence, especially regarding the inconsistencies in earning reports and the extremely high predicted future returns. The Hybrid Signal suggest to buy with caution. Monitoring news and company announcements will be crucial in assessing UNH's future prospects. The technical indicators suggest a potential buying opportunity could emerge *if* the downward trend reverses and the stock becomes oversold.
